Advanced Breath Diagnostics

Cairn Diagnostics, formerly known as Advanced Breath Diagnostics, is a medical technology company that develops and commercializes non-invasive breath tests for gastrointestinal and metabolic disorders. The company's primary product is the 13C-Spirulina Gastric Emptying Breath Test (GEBT), an FDA-approved diagnostic tool for gastroparesis that utilizes stable isotope technology. Unlike traditional scintigraphy, GEBT is non-radioactive and can be administered in a physician's office, providing a more accessible diagnostic option for patients. Cairn's platform is designed to measure physiological functions through the analysis of exhaled breath, with ongoing research into additional indications. The company focuses on providing standardized, validated testing solutions that improve patient management in gastroenterology.